课题基金 / 基金详情

Photothermal imaging of biomimetic nanoparticles to investigate the real-time dynamics of transcription at the single molecule level in living cells

Photothermal imaging of biomimetic nanoparticles to investigate the real-time dynamics of transcription at the single molecule level in living cells
仿生纳米粒子的光热成像研究活细胞中单分子水平转录的实时动态
批准号:
BB/D020638/1
负责人:
Raphael Levy
金额:
$89.77万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2006
资助国家:
英国
项目状态:
已结题
起止时间:
2006 至 --

项目摘要

项目成果

Raphael Levy的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the greatest challenges in biology is to be able to measure biological reactions as they happen in single cells. One important process is transcription, the reaction in which the DNA sequence of a gene is read by a polymerase to produce an RNA which is then translated to produce a protein. Transcription has been monitored indirectly in single cells through imaging of the synthesis of the firefly luciferase reporter protein in cells since it makes living cells glow and can therefore be measured using a camera that counts photons. Biological processes in living cells can also be monitored by microscopy using naturally fluorescent proteins which are genetically synthesised in the cell fused to proteins of interest. Over the past 10 years this has led to a revolution in cell biology because for the first time single biological processes such as protein movement can be watched as they happen in single cells. The Centre for Cell Imaging in Liverpool has been a leading centre in the development and application of these technologies. Using these approaches it is not generally possible to watch the movement of single molecules in cells. This would allow a new level of understanding of many biological processes. The ability to study in a single cell exactly when transcription is switched on by activating proteins (called transcription factors) is an important objective. It is becoming clear that these events may often be governed by probability and that averaging such processes or measuring them indirectly misses important information. I pioneered the development of biomimetic gold nanoparticles which can be easily coupled to proteins. Due to the small size of the nanoparticles the resulting molecules can behave in the same way as the normal protein. I will build the world's second photothermal microscope, which will be the first to be specifically designed to study living cells (with Lounis, Bordeaux, and White, Liverpool). This microscope allows the easy visualisation of gold and silver nanoparticles in optically complex environments. This has many applications in the important emerging field of nanobiotechnology. Using this new microscope we will be able to see single nanoparticles within living cells for long periods of time without any loss of signal and without damaging the cell. I will continue to develop biomimetic nanoparticles and optimise their ability to couple to functional proteins and other molecules that can be used to label biological processes (with Brust, Liverpool, and Desbat, Bordeaux). At present it would be necessary to bind proteins to the nanoparticles in the test tube outside the cell and then to introduce the resulting conjugate into the cell. This has the disadvantage that it takes time to purify the protein and has the risk that the protein may not be fully functional. I will therefore develop a new methodology for binding nanoparticles to proteins within cells (with Johnsson, Lausanne). The nanoparticles will be introduced into the cell where they can specifically couple with the protein of interest. I will use this technology to study transcription at single genes in living cells. I will use a combination of gold and silver nanoparticles which can be distinguished from each other to allow different processes to be watched at the same time. The first aim will be to use triple helix forming oligos (which form stable and specific interactions with specific double stranded DNA target sequences) to identify the position of single genes in the mammalian cell nucleus (with Jackson, Manchester, and Giovannangeli, Paris). I will then use nanoparticles to study the binding of single transcription factor molecules to the gene. I will mark the gene by introducing protein binding sites into the RNA so that the early RNA produced by transcription can be also be visualised. This will for the first time allow the processes that switch genes on to be studied at single genes.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3402/nano.v1i0.4889
发表时间: 2010
期刊: Nano reviews
影响因子: --
作者: [Lévy R, Shaheen U, Cesbron Y, Sée V]
通讯作者: Sée V
DOI: 10.1098/rsos.140454
发表时间: 2015-06
期刊: Royal Society open science
影响因子: 3.5
作者: [Nieves DJ, Li Y, Fernig DG, Lévy R]
通讯作者: Lévy R
DOI: 10.1371/journal.pone.0121683
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Cesbron Y, Shaheen U, Free P, Lévy R]
通讯作者: Lévy R
DOI: 10.1007/s11671-007-9065-5
发表时间: 2007-06-15
期刊: Nanoscale Research Letters
影响因子: --
作者: [Bernard C, Aimé JP, Marsaudon S, Levy R, Bonnot AM, Nguyen C, Mariolle D, Bertin F, Chabli A]
通讯作者: Chabli A
3DBioNet: an integrated technological platform for 3D micro-tissues
  • 批准号:
    MR/R025762/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $79.77万
  • 财政年份:
    2018
  • 负责人:
    Raphael Levy
  • 依托单位:
MICA: Liverpool Imaging Partnership: Molecular physiology and drug response
  • 批准号:
    MR/K015931/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $119.56万
  • 财政年份:
    2013
  • 负责人:
    Raphael Levy
  • 依托单位:
国内基金
海外基金
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
  • 批准号:
    82372015
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    熊丽琴
  • 依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
  • 批准号:
    82371912
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    吴广宇
  • 依托单位:
神经系统中大麻素CB1受体与周期性细胞骨架相互作用的机制和功能研究
  • 批准号:
    32100555
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.0万元
  • 批准年份:
    2021
  • 负责人:
    李卉
  • 依托单位: